Ocular HSV-1 latency, reactivation and recurrent disease. - Wikidata - awgldk - TriplyDB

Ocular HSV-1 latency, reactivation and recurrent disease.

Ocular HSV-1 latency, reactivation and recurrent disease.

http://www.wikidata.org/entity/Q37201603

about

Antiviral treatment and other therapeutic interventions for herpes simplex virus epithelial keratitis HSV-1 infection of human brain cells induces miRNA-146a and Alzheimer-type inflammatory signaling A double-blind placebo-controlled study to evaluate valacyclovir alone and with aspirin for asymptomatic HSV-1 DNA shedding in human tears and saliva The role of the CoREST/REST repressor complex in herpes simplex virus 1 productive infection and in latency Ocular herpes simplex virus: how are latency, reactivation, recurrent disease and therapy interrelated?Ganciclovir ophthalmic gel 0.15% for the treatment of acute herpetic keratitis: background, effectiveness, tolerability, safety, and future applications Mucosal treatments for herpes simplex virus: insights on targeted immunoprophylaxis and therapy Changes to euchromatin on LAT and ICP4 following reactivation are more prevalent in an efficiently reactivating strain of HSV-1.Effect of high versus low oral doses of valacyclovir on herpes simplex virus-1 DNA shedding into tears of latently infected rabbits.Acyclovir or Aβ42 peptides attenuate HSV-1-induced miRNA-146a levels in human primary brain cells.HSV-1 infection of human corneal epithelial cells: receptor-mediated entry and trends of re-infection.Ocular herpes simplex virus type 1: is the cornea a reservoir for viral latency or a fast pit stop?Upregulation of mouse genes in HSV-1 latent TG after butyrate treatment implicates the multiple roles of the LAT-ICP0 locus.Activation of checkpoint kinase 2 is critical for herpes simplex virus type 1 replication in corneal epithelium Frequency of dendritiform inflammatory cells in the cornea in herpetic anterior uveitis without clinical keratitis and Fuchs uveitis Efficient generation and rapid isolation via stoplight recombination of Herpes simplex viruses expressing model antigenic and immunological epitopes.HSV-1 miR-H6 inhibits HSV-1 replication and IL-6 expression in human corneal epithelial cells in vitro.Changes in Corneal Innervation after HSV-1 Latency Established with Different Reactivation Phenotypes.Decreased reactivation of a herpes simplex virus type 1 (HSV-1) latency-associated transcript (LAT) mutant using the in vivo mouse UV-B model of induced reactivation.Rabbit and mouse models of HSV-1 latency, reactivation, and recurrent eye diseases Rabbit Models for Studying Human Infectious Diseases.HSV-1 latent rabbits shed viral DNA into their saliva.HSV carrying WT REST establishes latency but reactivates only if the synthesis of REST is suppressed.Intracerebral propagation of Alzheimer's disease: strengthening evidence of a herpes simplex virus etiology ICP4-induced miR-101 attenuates HSV-1 replication Treatment of herpes simplex virus infections in pediatric patients: current status and future needs.Host responses to wild-type and attenuated herpes simplex virus infection in the absence of Stat1 New concepts in herpes simplex virus vaccine development: notes from the battlefield.Association between unprotected ultraviolet radiation exposure and recurrence of ocular herpes simplex virus.Inhibition of ataxia telangiectasia mutated (ATM) kinase suppresses herpes simplex virus type 1 (HSV-1) keratitis.The antimicrobial agent C31G is effective for therapy for HSV-1 ocular keratitis in the rabbit eye model.Nonthermal Dielectric Barrier Discharge (DBD) Plasma Suppresses Herpes Simplex Virus Type 1 (HSV-1) Replication in Corneal Epithelium.Zinc oxide tetrapods inhibit herpes simplex virus infection of cultured corneas.Prior Corneal Scarification and Injection of Immune Serum are Not Required Before Ocular HSV-1 Infection for UV-B-Induced Virus Reactivation and Recurrent Herpetic Corneal Disease in Latently Infected Mice.The eye in sexually transmitted infections: a review of the ocular complications of venereal diseases.Early events in herpes simplex virus lifecycle with implications for an infection of lifetime The miRNAs of herpes simplex virus (HSV).MicroRNAs in the brain: it's regulatory role in neuroinflammation.Canine herpesvirus-1 ocular diseases of mature dogs.Ocular herpes: the pathophysiology, management and treatment of herpetic eye diseases.

P2860

Q24235637-F84AD7CF-3AAA-4AEF-B8C6-AB91D36C1542 Q24611853-0DADB2F5-17FC-4B09-8E23-7275FBF38531 Q24622287-41F99A11-0400-4709-AD3A-517510379C3D Q26823532-B86D3260-8143-4451-A8E1-3ED2906FDE69 Q27021069-3FD7B8F0-86F4-41C0-B68F-28D47FEE54E1 Q27026675-D6C363F2-A6A7-4BC5-8CF7-A67379089CCE Q33710019-F34073C6-8BDC-4545-981E-D2AFB393C5F5 Q33747905-A56725CF-C728-4F6D-8659-6B442F8441F9 Q34135575-53E72A2A-3418-460B-89E8-5285DD4B98AE Q34191283-C7DF6D23-F542-4627-B2A0-94090C610011 Q34366070-F5229B74-612F-46AF-8344-22820C91A088 Q34685820-773841E0-F42A-40AF-B46D-394965C22EDD Q35005866-7203449F-1EE7-469F-AB8B-06747D3EC262 Q35235196-E3110A88-3EEA-4D9A-A4B3-EA98A4DD03E8 Q35388501-F357D513-90B7-4D41-BA5F-0EC339E86118 Q35645299-4ED8180C-B0D4-4135-A16A-78B24BC10A30 Q35896981-830BDD49-DC28-41CC-9BD4-4388D0309BF3 Q36055513-708FE7FC-161A-428E-81F3-5BEC51C37545 Q36199997-B08773C0-E9CB-41B7-978F-6546CEF15929 Q36307684-09BB1AD6-9025-4B33-B668-D143ADDE062B Q36376979-7D87A2B9-539F-419D-85DC-2B871AF28B9B Q36459433-C21D7A73-E63E-4B74-8BBC-FBDB22B95988 Q36598134-A2B769A7-48C4-43EE-AFE1-81544CC5D1C7 Q36628425-925F1F5B-5384-45B0-B084-913608E5A024 Q36694202-7752FD25-6DA6-4D5F-AA42-A72952D3849A Q36938445-8B5475E1-99F7-4E37-804B-8EFB78499578 Q37099709-38A3FC52-DF89-4A0C-8298-146A2B7D3F3C Q37384857-232D2275-A112-460C-8704-A311C7252565 Q37414696-9392EBD1-4EFA-43C6-A735-121CBFB8229D Q37551831-B7818D07-B9FA-4C9F-8B9D-A833761159F4 Q37590904-306F7C11-3E63-4FDB-8D46-0E05D97EFC52 Q37671413-2DB099EC-5495-4911-BDE5-E9A7996B0E03 Q37677460-85E1ECC5-9480-47DD-A56D-FA276B3AD2F5 Q37699104-17F0876E-B65C-4295-AA57-AFADAA0F6D3B Q37973011-4D790D05-D291-4EE7-A72D-25CD42F4455F Q37980142-CE83617B-7BB5-4052-96AC-113C0CC7FA85 Q38062478-B65D56B2-28BF-4924-AAB3-DFF3610891F4 Q38073708-F889A622-2F72-46EF-8F1D-F081F5A1DE08 Q38084402-9525E041-E734-4E28-95FA-6DA806F79999 Q38303228-FEEB4887-26DE-4BDD-9C96-AE60EA435A95

P2860

Ocular HSV-1 latency, reactivation and recurrent disease.

http://www.wikidata.org/entity/Q37201603

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on July 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Ocular HSV-1 latency, reactivation and recurrent disease.

@en

Ocular HSV-1 latency, reactivation and recurrent disease.

@nl

type

label

Ocular HSV-1 latency, reactivation and recurrent disease.

@en

Ocular HSV-1 latency, reactivation and recurrent disease.

@nl

prefLabel

Ocular HSV-1 latency, reactivation and recurrent disease.

@en

Ocular HSV-1 latency, reactivation and recurrent disease.

@nl

P1433

Q37201603-6593C0EE-ECC1-4B07-8C26-406C6128ED97

P1476

Q37201603-9D7DB739-BCDF-41B9-93D4-529F54830329

P2093

Q37201603-18C27B7D-D157-4A6E-8356-C8451E86C068

Q37201603-468A5004-8489-454C-805B-C516C62447A0

Q37201603-4ECB7EA1-FD06-4FF5-BBE7-05807DBD5319

Q37201603-53CC8DB3-C08F-45D8-AB54-32C1A579A7C6

Q37201603-7BD7F3C9-E65D-4684-AD1D-DD8A773EDBA0

Q37201603-811F8EF5-6B6B-4B11-9B59-B1A658B16618

Q37201603-88B2FC83-DFB3-4922-AEC4-FB034C7B8C69

P2860

Q37201603-0462E6A8-7232-405B-A963-E6DFB1C0EDC8

Q37201603-0557DA7E-FEE3-40EF-98E4-82D2E83B04FF

Q37201603-0708BB37-E542-471B-9BF0-E537C377C3BD

Q37201603-08C9DD37-746F-4C8F-A234-9AF27F563F45

Q37201603-09F470B3-D750-4F37-B0CA-B3CA0363237B

Q37201603-0B0F2B05-ACDA-4E98-B065-2AA7AC82B0C1

Q37201603-0EDAB438-117B-425D-B572-9AFC9A78ECE6

Q37201603-0EDB125E-A1C1-4761-B2EF-D8CA137E02C7

Q37201603-11096CAE-5E58-4305-A7D3-3475913AE2FF

Q37201603-12C9CA3F-A2FB-4DD5-A74A-374067DBA305

P304

Q37201603-433BE76A-1E25-4309-AF79-F17832713A94

P31

Q37201603-2FE7319E-90B6-4277-8F87-321C5FBA5488

P356

Q37201603-F02BFD4D-C591-46F8-8928-50369DA6EEE4

P407

Q37201603-B8728522-1406-4337-9EAC-9866B487A1F7

P433

Q37201603-54CCFC92-2F8A-4E03-A956-9B462EF136FB

P478

Q37201603-D95AFE32-F168-4E0E-823B-E45CE3F5A571

P50

Q37201603-896BED07-8FB1-47A3-A558-0108D3E9B14B

P577

Q37201603-504CD338-3510-437D-8448-17B3791FCBEB

P698

Q37201603-D1425472-81D6-4840-9FFA-60B42EF69744

P356

08820530802111085

P1433

Seminars in Ophthalmology

P1476

Ocular HSV-1 latency, reactivation and recurrent disease

@en

P2093

Andrea T Murina

http://www.w3.org/2001/XMLSchema#string

Donna M Neumann

http://www.w3.org/2001/XMLSchema#string

Hassanain S Toma

http://www.w3.org/2001/XMLSchema#string

Herbert E Kaufman

http://www.w3.org/2001/XMLSchema#string

James M Hill

http://www.w3.org/2001/XMLSchema#string

Partha S Bhattacharjee

http://www.w3.org/2001/XMLSchema#string

Timothy P Foster

http://www.w3.org/2001/XMLSchema#string

P2860

Translating the Histone Code

Egress of alphaherpesviruses: comparative ultrastructural study

HSV-1 DNA in tears and saliva of normal adults

Herpesviral latency-associated transcript gene promotes assembly of heterochromatin on viral lytic-gene promoters in latent infection.

A chromatin insulator-like element in the herpes simplex virus type 1 latency-associated transcript region binds CCCTC-binding factor and displays enhancer-blocking and silencing activities.

Herpes simplex virus latency-associated transcript is a stable intron

Spontaneous reactivation of herpes simplex virus type 1 in latently infected murine sensory ganglia

Herpes simplex virus type 1 mediates fusion through a hemifusion intermediate by sequential activity of glycoproteins D, H, L, and B

CTCF-dependent chromatin boundary element between the latency-associated transcript and ICP0 promoters in the herpes simplex virus type 1 genome

Selective retention of herpes simplex virus-specific T cells in latently infected human trigeminal ganglia

P304

249-273

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/08820530802111085

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

23

http://www.w3.org/2001/XMLSchema#string

P50

Raymond G Areaux

P577

2008-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18584563

http://www.w3.org/2001/XMLSchema#string